- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01888146
Pain Program for Active Coping & Training (PPACT-UH2)
Collaborative Care for Chronic Pain in Primary Care
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pain is a common and very costly public health problem. Common chronic pain conditions are expensive and pervasive, affecting at least 116 million American adults at an annual cost of $560 billion in direct medical treatment costs and lost productivity, and disproportionally affect vulnerable populations. Pain is the primary reason patients seek medical care and, as the first point of contact, primary care providers (PCPs) deliver the majority of that care. Unfortunately, PCPs face many challenges in managing these patients' care and often have little specific training in pain medicine. Yet with proper system support, PCPs are in the best position to coordinate pain management longitudinally. While pharmacotherapy is the predominant treatment approach for many PCPs, this limits the patient's role to taking medication, and he or she can become a passive recipient of care-leading to poor outcomes, potential overmedication, and possible disillusionment with the medical system. Further, increases in opiate prescribing for pain treatment -amidst increasing awareness of adverse outcomes, including addiction-and limited efficacy suggest the importance of broader treatment approaches that focus on patients' improvement of functioning. Although opiates may reduce pain symptoms while prescribed, patients are unlikely to experience significant and sustained improvements without the use of other nonpharmacologic pain management approaches. Medical management of patients with persistent pain and complex problems is often fragmented, which leads patients to seek a wide variety of primary and specialty care services in an effort to manage their pain and related conditions. Such fragmented care leads to poorer outcomes and significantly increases health care costs as patients often receive unneeded diagnostic and medical procedures. While research has identified evidence-based multidisciplinary behavioral treatment approaches that are effective for such patients and can even prevent the disability associated with persistent pain when offered earlier in the course of care, these interventions are rarely available in everyday practice settings and will require data from pragmatic clinical trials to change the care paradigm.
To address these issues, we are proposing a mixed-methods, cluster-randomized pragmatic clinical trial that will evaluate the integration of psychosocial services within the primary care environment. This project will implement an intervention into everyday clinical practice flow utilizing assessment measures and intervention staff directly from the clinical care system rather than utilizing a research-developed and administered structure. The intervention will be an integrated program that will guide all care for intervention patients. We will compare this primary care-based intervention to usual care using systematic, clinic-based assessments. During the initial phase, we will pilot the intervention with up to 50 patients in the Kaiser Permanente Northwest (KPNW) region with patients selected by their primary care providers who have non-malignant chronic pain (pain persisting for ≥ 3 months) and who are on long-term opiate therapy for the treatment of their condition. This pilot portion of the project is in preparation for the effective implementation of a large-scale, cluster-randomized pragmatic clinical trial to be conducted throughout three regions of Kaiser Permanente - Northwest, Georgia, and Hawaii comparing this primary care based multidisciplinary intervention to usual care in these settings.
This intervention brings together elements often available in health plans but organized in a less integrated fashion, and it will ensure flexibility in implementation to best fit individual clinic environments and the needs of chronic pain patients on long-term opiate therapy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97227
- Kaiser Permanente Center for Health Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Paneled to a primary care provider practicing at one of the primary care clinics participating in the study
- ≥18 years of age at time of inclusion. Current adult KP member (18 years or older)
Within the last 180 days either:
- 90 day supply of short acting opioid spanning at least 120 days
- or more long acting opioid dispenses
Pain diagnostic ICD-9 code within the past 180 days
- Diagnostic categories include but are not limited to: Back pain, neck pain, fibromyalgia, arthritis, myofascial pain, neuropathies, migraine, tension headache, temporomandibular joint disorder, carpal tunnel syndrome, nonspecific chronic pain, abdominal pain, pelvic pain
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Interdisciplinary pain program
Interdisciplinary pain program, which includes behavioral health, nurse case management, physical therapy, and pharmacy embedded in primary care.
|
Interdisciplinary pain program, which includes behavioral health, nurse case management, physical therapy, and pharmacy embedded in primary care.
|
|
NO_INTERVENTION: Treatment as usual
Patients in this arm will receive care as usual and utilize services as they currently exist in the health plan system.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brief Pain Inventory
Time Frame: Collected every 3 months for 1 year
|
Reliable and valid tool that measures patients' pain intensity and functional interference.
|
Collected every 3 months for 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health care utilization and cost
Time Frame: Collected every 3 months for 1 year
|
Primary care and specialty care services
|
Collected every 3 months for 1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Morphine equivalents
Time Frame: Collected every 3 months for 1 year
|
Opioid dose measured in morphine equivalents
|
Collected every 3 months for 1 year
|
|
Patient satisfaction
Time Frame: Collected every 3 months for 1 year
|
Patient satisfaction with health care services
|
Collected every 3 months for 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lynn DeBar, PhD, MHP, Kaiser Permanente
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1UH2AT007788-01 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Non-malignant Pain
-
DurectCompletedChronic, Non Malignant PainUnited States
-
Haben Tesfu GebreselassieCompletedNon-malignant Chronic PainTurkey
-
Norwegian University of Science and TechnologyCompletedNon-malignant Chronic Pain
-
Purdue Pharma LPTerminatedChronic Non-Malignant PainUnited States
-
Kaiser PermanenteNational Institute of Neurological Disorders and Stroke (NINDS); Duke University and other collaboratorsCompleted
-
Purdue Pharma LPNapp Pharmaceuticals LimitedCompletedChronic Non-malignant PainUnited States, United Kingdom
-
University of LiegeUnknownComparison of Treatment for Chronic Non-malignant and Malignant PainBelgium
-
MedtronicNeuroCompletedChronic Pain | Pain, Back | Chronic Non-malignant Pain | Pain, LegUnited States
-
Zealand University HospitalCompletedChronic Pain | Non-malignant PainDenmark
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
Clinical Trials on Interdisciplinary pain program
-
Federal University of Espirito SantoNot yet recruiting
-
Linkoeping UniversityOstergotland County Council, SwedenRecruitingOverweight and Obesity | Pain, Chronic | Mobile Phone Use | Nutrition PoorSweden
-
Kaiser PermanenteNational Institute of Neurological Disorders and Stroke (NINDS); Duke University and other collaboratorsCompleted
-
Mary Free Bed Rehabilitation HospitalCompleted
-
Linkoeping UniversityActive, not recruiting
-
Technical University of MunichGerman Research Foundation; Technical University of Munich, Faculty of Medicine and other collaboratorsCompletedChronic Pain, Interdisciplinary Multimodal Pain Therapy, Electroencephalography, Functional ConnectivityGermany
-
Grupo Rehabilitacion en SaludInstituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) and other collaboratorsActive, not recruitingHeart FailureColombia
-
Chang Gung Memorial HospitalNational Health Research Institutes, TaiwanCompleted
-
Chang Gung Memorial HospitalNational Health Research Institutes, TaiwanCompletedDiabetes Mellitus | Hip FractureTaiwan
-
Maastricht UniversityPfizer; Centrum voor Integrale Revalidatie (CIR)Active, not recruitingOsteoarthritis | Chronic Pain | Disability PhysicalNetherlands